Read More
FDA approves new drug to treat patients with myelofibrosis
Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Read More
Subscribe to:
Post Comments (Atom)
0 Response to "FDA approves new drug to treat patients with myelofibrosis"
Post a Comment